Anthropic’s Claude AI Reportedly Used in U.S. Operation to Capture Nicolas Maduro 
Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings 
Mitsui Kinzoku Stock Surges to Record High After Profit Forecast Upgrade and Dividend Increase 
Santos Wins Court Case Over Net Zero and Sustainability Claims 
NAB Shares Hit Record High as First-Quarter Cash Earnings Jump 16% 
Macquarie-Led Consortium to Acquire Qube Holdings in A$11.7 Billion Deal 
Thomas Pritzker to Step Down as Hyatt Executive Chairman After Epstein Ties Acknowledged 
Waymo Clarifies Role of Remote Workers Amid U.S. Robotaxi Safety Scrutiny 
Reese’s Peanut Butter Cup Recipe Debate: Hershey Responds as Cocoa Prices Shift 
YouTube Outage Disrupts Thousands Worldwide as Recommendation System Fails 
Goldman Sachs Reportedly Drops Diversity Criteria From Board Candidate Evaluations 
Federal Court Fines Mobil Oil Australia A$16 Million for Misleading Fuel Claims 
Freedom Finance and Binance Join Forces in Digital Assets 
Hedge Funds Cut Nvidia, Amazon and Microsoft Stakes as AI Valuation Concerns Rise 
BHP Group Half-Year Profit Surges as Copper Overtakes Iron Ore on AI-Driven Demand 
European IT Hardware Stocks to Watch as Gaming Demand Outpaces Smartphones, Says BofA 
Starboard Value Targets Tripadvisor Board Overhaul Amid Stock Slump 
PARSIPPANY, N.J., May 01, 2018 -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that members of its management team are scheduled to present at the following two healthcare conferences:
- Deutsche Bank 43rd Annual Health Care Conference in Boston, on Wednesday, May 9 at 2:10 PM ET
- Bank of America Merrill Lynch 2018 Healthcare Conference in Las Vegas, on Tuesday, May 15, at 1:40 PM PT (4:40PM ET)
A live audio webcast of the Pacira presentations can be accessed by visiting the “Investors & Media” section of the company’s website at investor.pacira.com. A replay of the webcasts will be archived on the Pacira website for two weeks following the presentation dates.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is a specialty pharmaceutical company dedicated to advancing and improving postsurgical outcomes for acute care practitioners and their patients. The company’s flagship product, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.
Company Contact: Pacira Pharmaceuticals, Inc. Christian Pedetti (973) 254-4387 [email protected]
